Entity Common Stock, Shares Outstanding of Sigyn Therapeutics, Inc. from 03 Dec 2015 to 05 Sep 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Sigyn Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 03 Dec 2015 to 05 Sep 2025.
  • Sigyn Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 05 Sep 2025 was 1,605,377.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Sigyn Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 1,605,377 05 Sep 2025 10-Q 05 Sep 2025 2025 Q2
Q2 2025 1,605,377 +341,724 +27% 20 May 2025 10-Q 20 May 2025 2025 Q1
Q1 2025 1,605,377 +380,550 +31% 11 Apr 2025 10-K 15 Apr 2025 2024 FY
Q4 2024 1,605,378 19 Nov 2024 10-Q 19 Nov 2024 2024 Q3
Q2 2024 1,263,653 -42,967,749 -97% 14 Aug 2024 10-Q 19 Aug 2024 2024 Q2
Q1 2024 1,224,827 -41,488,498 -97% 14 May 2024 10-Q 14 May 2024 2024 Q1
Q3 2023 51,536,602 +14,240,789 +38% 10 Nov 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 44,231,402 11 Aug 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 42,713,325 +5,417,522 +15% 31 Mar 2023 10-K 31 Mar 2023 2022 FY
Q3 2022 37,295,813 +10 0% 14 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q1 2022 37,295,803 +2,047,290 +5.8% 14 Mar 2022 10-K 21 Mar 2022 2021 FY
Q3 2021 37,295,803 +3,109,634 +9.1% 12 Nov 2021 10-Q 12 Nov 2021 2021 Q3
Q1 2021 35,248,513 -58,023,895 -62% 05 Apr 2021 10-K 06 Apr 2021 2020 FY
Q3 2020 34,186,169 -47,086,239 -58% 06 Nov 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 95,772,408 +14,500,000 +18% 07 Aug 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 93,272,408 +12,000,000 +15% 30 Mar 2020 10-K 30 Mar 2020 2019 FY
Q3 2019 81,272,408 +10,500,000 +15% 11 Nov 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 81,272,408 +18,240,000 +29% 31 Jul 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 81,272,408 +24,162,400 +42% 01 Apr 2019 10-K 01 Apr 2019 2018 FY
Q3 2018 70,772,408 +18,564,086 +36% 14 Nov 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 63,032,408 +19,222,854 +44% 14 Aug 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 57,110,008 02 Apr 2018 10-K 02 Apr 2018 2017 FY
Q3 2017 52,208,322 +15,818,635 +43% 13 Nov 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 43,809,554 +9,186,554 +27% 30 May 2017 10-Q 02 Jun 2017 2017 Q1
Q3 2016 36,389,687 14 Nov 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 34,623,000 04 Aug 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 34,323,000 30 Mar 2016 10-K 30 Mar 2016 2015 FY
Q4 2015 31,823,000 03 Dec 2015 10-Q 21 Dec 2015 2015 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.